APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bismuth Subnitrate Intramammary Infusion

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bismuth Subnitrate Intramammary Infusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchBismuth Subnitrate Intramammary Infusion Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Bismuth Subnitrate Intramammary Infusion Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Bismuth Subnitrate Intramammary Infusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bismuth Subnitrate Intramammary Infusion Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bismuth Subnitrate Intramammary Infusion Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Bismuth Subnitrate Intramammary Infusion market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bismuth Subnitrate Intramammary Infusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bismuth Subnitrate Intramammary Infusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bismuth Subnitrate Intramammary Infusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bismuth Subnitrate Intramammary Infusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bismuth Subnitrate Intramammary Infusion include Hisun Animal Healthcare Products, Zoetis, Zelpharma, Vetoquinol, Solvet, Norbrook, Merck Animal Health, Boehringer Ingelheim and Bioveta, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bismuth Subnitrate Intramammary Infusion market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bismuth Subnitrate Intramammary Infusion and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bismuth Subnitrate Intramammary Infusion sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bismuth Subnitrate Intramammary Infusion market size, projected growth trends, production technologies, key applications, and end-use industries.

Bismuth Subnitrate Intramammary Infusion Segment by Company

Hisun Animal Healthcare Products

Zoetis

Zelpharma

Vetoquinol

Solvet

Norbrook

Merck Animal Health

Boehringer Ingelheim

Bioveta

AVet Health

Bismuth Subnitrate Intramammary Infusion Segment by Type

Paste

Suspension

Bismuth Subnitrate Intramammary Infusion Segment by Application

Mastitis Treatment

Breast Infection Prevention

Bismuth Subnitrate Intramammary Infusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bismuth Subnitrate Intramammary Infusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bismuth Subnitrate Intramammary Infusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bismuth Subnitrate Intramammary Infusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bismuth Subnitrate Intramammary Infusion market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bismuth Subnitrate Intramammary Infusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bismuth Subnitrate Intramammary Infusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bismuth Subnitrate Intramammary Infusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bismuth Subnitrate Intramammary Infusion Industry Trends Table 2. Bismuth Subnitrate Intramammary Infusion Industry Drivers Table 3. Bismuth Subnitrate Intramammary Infusion Industry Opportunities and Challenges Table 4. Bismuth Subnitrate Intramammary Infusion Industry Restraints Table 5. Global Bismuth Subnitrate Intramammary Infusion Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bismuth Subnitrate Intramammary Infusion Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Manufacturers Table 9. Global Bismuth Subnitrate Intramammary Infusion Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bismuth Subnitrate Intramammary Infusion Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bismuth Subnitrate Intramammary Infusion Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bismuth Subnitrate Intramammary Infusion Manufacturers, Product Type & Application Table 13. Global Bismuth Subnitrate Intramammary Infusion Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bismuth Subnitrate Intramammary Infusion by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Paste Table 17. Major Manufacturers of Suspension Table 18. Global Bismuth Subnitrate Intramammary Infusion Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Bismuth Subnitrate Intramammary Infusion Sales by Type (2021-2026) & (K Units) Table 20. Global Bismuth Subnitrate Intramammary Infusion Sales by Type (2027-2032) & (K Units) Table 21. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Type (2021-2026) Table 22. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Type (2027-2032) Table 23. Global Bismuth Subnitrate Intramammary Infusion Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Bismuth Subnitrate Intramammary Infusion Revenue by Type (2021-2026) & (K Units) Table 25. Global Bismuth Subnitrate Intramammary Infusion Revenue by Type (2027-2032) & (K Units) Table 26. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Type (2021-2026) Table 27. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Mastitis Treatment Table 29. Major Manufacturers of Breast Infection Prevention Table 30. Global Bismuth Subnitrate Intramammary Infusion Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Bismuth Subnitrate Intramammary Infusion Sales by Application (2021-2026) & (K Units) Table 32. Global Bismuth Subnitrate Intramammary Infusion Sales by Application (2027-2032) & (K Units) Table 33. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Application (2021-2026) Table 34. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Application (2027-2032) Table 35. Global Bismuth Subnitrate Intramammary Infusion Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Bismuth Subnitrate Intramammary Infusion Revenue by Application (2021-2026) & (K Units) Table 37. Global Bismuth Subnitrate Intramammary Infusion Revenue by Application (2027-2032) & (K Units) Table 38. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Application (2021-2026) Table 39. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Application (2027-2032) Table 40. Global Bismuth Subnitrate Intramammary Infusion Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Bismuth Subnitrate Intramammary Infusion Sales by Region (2021-2026) & (K Units) Table 42. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Region (2021-2026) Table 43. Global Bismuth Subnitrate Intramammary Infusion Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Bismuth Subnitrate Intramammary Infusion Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2026) & (K Units) Table 47. North America Bismuth Subnitrate Intramammary Infusion Sales by Country (2027-2032) & (K Units) Table 48. Europe Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2026) & (K Units) Table 50. Europe Bismuth Subnitrate Intramammary Infusion Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Bismuth Subnitrate Intramammary Infusion Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Sales by Country (2027-2032) & (K Units) Table 57. Global Bismuth Subnitrate Intramammary Infusion Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Bismuth Subnitrate Intramammary Infusion Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Bismuth Subnitrate Intramammary Infusion Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Region (2021-2026) Table 61. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Region (2027-2032) Table 62. Hisun Animal Healthcare Products Company Information Table 63. Hisun Animal Healthcare Products Business Overview Table 64. Hisun Animal Healthcare Products Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Hisun Animal Healthcare Products Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 66. Hisun Animal Healthcare Products Recent Development Table 67. Zoetis Company Information Table 68. Zoetis Business Overview Table 69. Zoetis Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zoetis Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 71. Zoetis Recent Development Table 72. Zelpharma Company Information Table 73. Zelpharma Business Overview Table 74. Zelpharma Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Zelpharma Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 76. Zelpharma Recent Development Table 77. Vetoquinol Company Information Table 78. Vetoquinol Business Overview Table 79. Vetoquinol Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Vetoquinol Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 81. Vetoquinol Recent Development Table 82. Solvet Company Information Table 83. Solvet Business Overview Table 84. Solvet Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Solvet Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 86. Solvet Recent Development Table 87. Norbrook Company Information Table 88. Norbrook Business Overview Table 89. Norbrook Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Norbrook Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 91. Norbrook Recent Development Table 92. Merck Animal Health Company Information Table 93. Merck Animal Health Business Overview Table 94. Merck Animal Health Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Merck Animal Health Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 96. Merck Animal Health Recent Development Table 97. Boehringer Ingelheim Company Information Table 98. Boehringer Ingelheim Business Overview Table 99. Boehringer Ingelheim Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Boehringer Ingelheim Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 101. Boehringer Ingelheim Recent Development Table 102. Bioveta Company Information Table 103. Bioveta Business Overview Table 104. Bioveta Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Bioveta Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 106. Bioveta Recent Development Table 107. AVet Health Company Information Table 108. AVet Health Business Overview Table 109. AVet Health Bismuth Subnitrate Intramammary Infusion Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. AVet Health Bismuth Subnitrate Intramammary Infusion Product Portfolio Table 111. AVet Health Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Bismuth Subnitrate Intramammary Infusion Distributors List Table 115. Bismuth Subnitrate Intramammary Infusion Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Bismuth Subnitrate Intramammary Infusion Product Image Figure 2. Global Bismuth Subnitrate Intramammary Infusion Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bismuth Subnitrate Intramammary Infusion Market Size (2021-2032) & (US$ Million) Figure 4. Global Bismuth Subnitrate Intramammary Infusion Sales (2021-2032) & (K Units) Figure 5. Global Bismuth Subnitrate Intramammary Infusion Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bismuth Subnitrate Intramammary Infusion Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Paste Image Figure 9. Suspension Image Figure 10. Global Bismuth Subnitrate Intramammary Infusion Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Type (2021-2032) Figure 13. Global Bismuth Subnitrate Intramammary Infusion Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Type (2021-2032) Figure 16. Mastitis Treatment Image Figure 17. Breast Infection Prevention Image Figure 18. Global Bismuth Subnitrate Intramammary Infusion Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Application (2021-2032) Figure 21. Global Bismuth Subnitrate Intramammary Infusion Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Application (2021-2032) Figure 24. North America Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Bismuth Subnitrate Intramammary Infusion Sales Market Share by Country (2021-2032) Figure 26. U.S. Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Bismuth Subnitrate Intramammary Infusion Sales Market Share by Country (2021-2032) Figure 31. Germany Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Bismuth Subnitrate Intramammary Infusion Sales Market Share by Country (2021-2032) Figure 38. China Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Sales Market Share by Country (2021-2032) Figure 46. Brazil Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Bismuth Subnitrate Intramammary Infusion Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Bismuth Subnitrate Intramammary Infusion Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032) & (US$ Million) Figure 57. North America Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032) & (US$ Million) Figure 59. Europe Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Bismuth Subnitrate Intramammary Infusion Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Bismuth Subnitrate Intramammary Infusion Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Paste
  • Suspension
Applications
  • Mastitis Treatment
  • Breast Infection Prevention
Companies covered
  • Hisun Animal Healthcare Products
  • Zoetis
  • Zelpharma
  • Vetoquinol
  • Solvet
  • Norbrook
  • Merck Animal Health
  • Boehringer Ingelheim
  • Bioveta
  • AVet Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bismuth Subnitrate Intramammary Infusion Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bismuth Subnitrate Intramammary Infusion Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bismuth Subnitrate Intramammary Infusion Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bismuth Subnitrate Intramammary Infusion Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bismuth Subnitrate Intramammary Infusion Market Dynamics
  1. 2.1 Bismuth Subnitrate Intramammary Infusion Industry Trends
  2. 2.2 Bismuth Subnitrate Intramammary Infusion Industry Drivers
  3. 2.3 Bismuth Subnitrate Intramammary Infusion Industry Opportunities and Challenges
  4. 2.4 Bismuth Subnitrate Intramammary Infusion Industry Restraints
3 Bismuth Subnitrate Intramammary Infusion Market by Manufacturers
  1. 3.1 Global Bismuth Subnitrate Intramammary Infusion Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bismuth Subnitrate Intramammary Infusion Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bismuth Subnitrate Intramammary Infusion Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bismuth Subnitrate Intramammary Infusion Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bismuth Subnitrate Intramammary Infusion Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bismuth Subnitrate Intramammary Infusion Manufacturers, Product Type & Application
  7. 3.7 Global Bismuth Subnitrate Intramammary Infusion Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bismuth Subnitrate Intramammary Infusion Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bismuth Subnitrate Intramammary Infusion Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bismuth Subnitrate Intramammary Infusion Tier 1, Tier 2, and Tier 3
4 Bismuth Subnitrate Intramammary Infusion Market by Type
  1. 4.1 Bismuth Subnitrate Intramammary Infusion Type Introduction
  2. 4.1.1 Paste
  3. 4.1.2 Suspension
  4. 4.2 Global Bismuth Subnitrate Intramammary Infusion Sales by Type
  5. 4.2.1 Global Bismuth Subnitrate Intramammary Infusion Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bismuth Subnitrate Intramammary Infusion Sales by Type (2021-2032)
  7. 4.2.3 Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bismuth Subnitrate Intramammary Infusion Revenue by Type
  9. 4.3.1 Global Bismuth Subnitrate Intramammary Infusion Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bismuth Subnitrate Intramammary Infusion Revenue by Type (2021-2032)
  11. 4.3.3 Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Type (2021-2032)
5 Bismuth Subnitrate Intramammary Infusion Market by Application
  1. 5.1 Bismuth Subnitrate Intramammary Infusion Application Introduction
  2. 5.1.1 Mastitis Treatment
  3. 5.1.2 Breast Infection Prevention
  4. 5.2 Global Bismuth Subnitrate Intramammary Infusion Sales by Application
  5. 5.2.1 Global Bismuth Subnitrate Intramammary Infusion Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bismuth Subnitrate Intramammary Infusion Sales by Application (2021-2032)
  7. 5.2.3 Global Bismuth Subnitrate Intramammary Infusion Sales Market Share by Application (2021-2032)
  8. 5.3 Global Bismuth Subnitrate Intramammary Infusion Revenue by Application
  9. 5.3.1 Global Bismuth Subnitrate Intramammary Infusion Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bismuth Subnitrate Intramammary Infusion Revenue by Application (2021-2032)
  11. 5.3.3 Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Application (2021-2032)
6 Global Bismuth Subnitrate Intramammary Infusion Sales by Region
  1. 6.1 Global Bismuth Subnitrate Intramammary Infusion Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bismuth Subnitrate Intramammary Infusion Sales by Region (2021-2032)
  3. 6.2.1 Global Bismuth Subnitrate Intramammary Infusion Sales by Region (2021-2026)
  4. 6.2.2 Global Bismuth Subnitrate Intramammary Infusion Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bismuth Subnitrate Intramammary Infusion Revenue by Region
  1. 7.1 Global Bismuth Subnitrate Intramammary Infusion Revenue by Region
  2. 7.1.1 Global Bismuth Subnitrate Intramammary Infusion Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bismuth Subnitrate Intramammary Infusion Revenue by Region (2021-2026)
  4. 7.1.3 Global Bismuth Subnitrate Intramammary Infusion Revenue by Region (2027-2032)
  5. 7.1.4 Global Bismuth Subnitrate Intramammary Infusion Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032)
  8. 7.2.2 North America Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032)
  11. 7.3.2 Europe Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bismuth Subnitrate Intramammary Infusion Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Hisun Animal Healthcare Products
  2. 8.1.1 Hisun Animal Healthcare Products Company Information
  3. 8.1.2 Hisun Animal Healthcare Products Business Overview
  4. 8.1.3 Hisun Animal Healthcare Products Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hisun Animal Healthcare Products Bismuth Subnitrate Intramammary Infusion Product Portfolio
  6. 8.1.5 Hisun Animal Healthcare Products Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Bismuth Subnitrate Intramammary Infusion Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Zelpharma
  14. 8.3.1 Zelpharma Company Information
  15. 8.3.2 Zelpharma Business Overview
  16. 8.3.3 Zelpharma Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zelpharma Bismuth Subnitrate Intramammary Infusion Product Portfolio
  18. 8.3.5 Zelpharma Recent Developments
  19. 8.4 Vetoquinol
  20. 8.4.1 Vetoquinol Company Information
  21. 8.4.2 Vetoquinol Business Overview
  22. 8.4.3 Vetoquinol Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vetoquinol Bismuth Subnitrate Intramammary Infusion Product Portfolio
  24. 8.4.5 Vetoquinol Recent Developments
  25. 8.5 Solvet
  26. 8.5.1 Solvet Company Information
  27. 8.5.2 Solvet Business Overview
  28. 8.5.3 Solvet Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Solvet Bismuth Subnitrate Intramammary Infusion Product Portfolio
  30. 8.5.5 Solvet Recent Developments
  31. 8.6 Norbrook
  32. 8.6.1 Norbrook Company Information
  33. 8.6.2 Norbrook Business Overview
  34. 8.6.3 Norbrook Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Norbrook Bismuth Subnitrate Intramammary Infusion Product Portfolio
  36. 8.6.5 Norbrook Recent Developments
  37. 8.7 Merck Animal Health
  38. 8.7.1 Merck Animal Health Company Information
  39. 8.7.2 Merck Animal Health Business Overview
  40. 8.7.3 Merck Animal Health Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Animal Health Bismuth Subnitrate Intramammary Infusion Product Portfolio
  42. 8.7.5 Merck Animal Health Recent Developments
  43. 8.8 Boehringer Ingelheim
  44. 8.8.1 Boehringer Ingelheim Company Information
  45. 8.8.2 Boehringer Ingelheim Business Overview
  46. 8.8.3 Boehringer Ingelheim Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim Bismuth Subnitrate Intramammary Infusion Product Portfolio
  48. 8.8.5 Boehringer Ingelheim Recent Developments
  49. 8.9 Bioveta
  50. 8.9.1 Bioveta Company Information
  51. 8.9.2 Bioveta Business Overview
  52. 8.9.3 Bioveta Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bioveta Bismuth Subnitrate Intramammary Infusion Product Portfolio
  54. 8.9.5 Bioveta Recent Developments
  55. 8.10 AVet Health
  56. 8.10.1 AVet Health Company Information
  57. 8.10.2 AVet Health Business Overview
  58. 8.10.3 AVet Health Bismuth Subnitrate Intramammary Infusion Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AVet Health Bismuth Subnitrate Intramammary Infusion Product Portfolio
  60. 8.10.5 AVet Health Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bismuth Subnitrate Intramammary Infusion Value Chain Analysis
  2. 9.1.1 Bismuth Subnitrate Intramammary Infusion Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bismuth Subnitrate Intramammary Infusion Production Mode & Process
  6. 9.2 Bismuth Subnitrate Intramammary Infusion Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bismuth Subnitrate Intramammary Infusion Distributors
  9. 9.2.3 Bismuth Subnitrate Intramammary Infusion Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst